Company intelligence / Profile preview

Synthegen

Houston, Texas, USA

Ownership: Private
Development stage: Other

Overview

Synthegen, LLC was a biotechnology company based in Houston, Texas, that specialized in the custom synthesis of modified oligonucleotides and fluorescently labeled probes. The company was recognized for its expertise in producing high-quality, complex synthetic DNA and RNA sequences for use in molecular biology research, diagnostics, and therapeutic development. Synthegen's product portfolio included a wide range of modifications such as quenchers, fluorophores, and unusual bases. In 2005, the company was acquired by Integrated DNA Technologies (IDT), which integrated Synthegen's specialized chemistry and production capabilities into its global operations.

Modalities: Synthetic oligonucleotideModified DNAModified RNA
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Synthegen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synthegen.

Explore the full profile